Lymph node biopsy

Results: 59



#Item
1SNAC trial results: Sentinel Node Biopsy versus Axillary Clearance The SNAC trial has helped researchers answer an important health question. It has provided evidence that will allow breast surgeons to choose the best ty

SNAC trial results: Sentinel Node Biopsy versus Axillary Clearance The SNAC trial has helped researchers answer an important health question. It has provided evidence that will allow breast surgeons to choose the best ty

Add to Reading List

Source URL: www.ctc.usyd.edu.au

Language: English - Date: 2016-03-21 02:34:59
2Current status of radioactive seed for localization of non palpable breast lesions

Current status of radioactive seed for localization of non palpable breast lesions

Add to Reading List

Source URL: www.teambest.com

Language: English - Date: 2016-03-22 17:25:57
3Paper RADIOACTIVE SEED LOCALIZATION WITH 125I FOR NONPALPABLE LESIONS PRIOR TO BREAST LUMPECTOMY AND/OR EXCISIONAL BIOPSY: METHODOLOGY, SAFETY, AND EXPERIENCE OF INITIAL YEAR Lawrence T. Dauer,*† Cynthia Thornton,† D

Paper RADIOACTIVE SEED LOCALIZATION WITH 125I FOR NONPALPABLE LESIONS PRIOR TO BREAST LUMPECTOMY AND/OR EXCISIONAL BIOPSY: METHODOLOGY, SAFETY, AND EXPERIENCE OF INITIAL YEAR Lawrence T. Dauer,*† Cynthia Thornton,† D

Add to Reading List

Source URL: www.teambest.com

Language: English - Date: 2016-03-22 17:28:38
4Revised after meeitng with Dr. NewmanReviewed with Dr. Valero, wording update for LCIS first treatment box, Breast Cancer (Noninvasive) DIAGNOSIS

Revised after meeitng with Dr. NewmanReviewed with Dr. Valero, wording update for LCIS first treatment box, Breast Cancer (Noninvasive) DIAGNOSIS

Add to Reading List

Source URL: www.rcctvm.org

Language: English - Date: 2007-09-18 09:59:30
53-Year Recurrence and Survival Outcomes after Sentinel Lymph Node Biopsy with 99m [ Tc]Tilmanocept in Clinically Node-Negative Breast Cancer and Melanoma Patients Stephen P. Povoski,  1

3-Year Recurrence and Survival Outcomes after Sentinel Lymph Node Biopsy with 99m [ Tc]Tilmanocept in Clinically Node-Negative Breast Cancer and Melanoma Patients Stephen P. Povoski, 1

Add to Reading List

Source URL: www.navidea.com

Language: English - Date: 2014-03-13 16:51:26
    6UNDERSTA NDING  NonSMALL CEL L LUNG CANCER

    UNDERSTA NDING NonSMALL CEL L LUNG CANCER

    Add to Reading List

    Source URL: www.lungcanceralliance.org

    Language: English - Date: 2013-12-06 14:26:59
    7Combined Analysis of Phase III Trials Evaluating [99mTc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma Vernon K. Sondak, Dennis W. King,

    Combined Analysis of Phase III Trials Evaluating [99mTc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma Vernon K. Sondak, Dennis W. King,

    Add to Reading List

    Source URL: www.navidea.com

    Language: English - Date: 2013-02-14 17:46:08
    8EXHIBIT A  Test Information Contact Betty Reeves to discuss TXCH Core Laboratory Clinical Service Agreements and pricingor

    EXHIBIT A Test Information Contact Betty Reeves to discuss TXCH Core Laboratory Clinical Service Agreements and pricingor

    Add to Reading List

    Source URL: txch.org

    Language: English - Date: 2014-12-17 16:45:49
    9Radioactive Materials Unit Minnesota Department of Health 625 Robert Street North PO BoxSt. Paul, Minnesota

    Radioactive Materials Unit Minnesota Department of Health 625 Robert Street North PO BoxSt. Paul, Minnesota

    Add to Reading List

    Source URL: www.health.state.mn.us

    Language: English - Date: 2014-05-21 11:04:52
    10GammaLōc® System Ce-139 Licensing Frequently Asked QuestionsRev 0  TITLE: Ce-139 FAQ

    GammaLōc® System Ce-139 Licensing Frequently Asked QuestionsRev 0 TITLE: Ce-139 FAQ

    Add to Reading List

    Source URL: www.dilon.com

    Language: English - Date: 2013-11-25 10:17:00